These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antagonists in the 5-phenyl-benzomorphan series. Clarke FH; Hill RT; Saelens JK; Yokoyama N Adv Biochem Psychopharmacol; 1973; 8(0):81-9. PubMed ID: 4211809 [No Abstract] [Full Text] [Related]
4. Perspectives in the chemistry of narcotic antagonists. Jacobson AE; May EL Adv Biochem Psychopharmacol; 1973; 8(0):187-9. PubMed ID: 4795005 [No Abstract] [Full Text] [Related]
5. Potent long-acting antagonists of the 9,9-dialkylbenzomorphan series. Janssen PA Adv Biochem Psychopharmacol; 1973; 8(0):109-11. PubMed ID: 4795015 [No Abstract] [Full Text] [Related]
6. Inhibition of writhing by narcotic antagonists. Pearl J; Harris LS J Pharmacol Exp Ther; 1966 Nov; 154(2):319-23. PubMed ID: 4380744 [No Abstract] [Full Text] [Related]
7. Recent progress in research on narcotic antagonists. Archer S; Michne WF Prog Drug Res; 1976; 20():45-100. PubMed ID: 189354 [No Abstract] [Full Text] [Related]
9. Ring C-bridged derivatives of thebaine and oripavine. Lewis JW Adv Biochem Psychopharmacol; 1973; 8(0):123-36. PubMed ID: 4795079 [No Abstract] [Full Text] [Related]
10. Interactions of narcotics an their antagonists with human serum esterase. IX: structure-activity relationships of morphinans and morphines. Bamberger MJ; Gero A Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):189-202. PubMed ID: 7224721 [TBL] [Abstract][Full Text] [Related]
11. Narcotic antagonists of the 4-phenylpiperidine series. Langbein A; Merz H; Stockhaus K; Wick H Adv Biochem Psychopharmacol; 1973; 8(0):157-65. PubMed ID: 4212187 [No Abstract] [Full Text] [Related]
12. Cyclorphan and related compounds. Gates M Adv Biochem Psychopharmacol; 1973; 8(0):51-6. PubMed ID: 4152824 [No Abstract] [Full Text] [Related]
13. Chemistry of narcotic antagonists of the nalorphine type. Robinson FM Adv Biochem Psychopharmacol; 1973; 8(0):21-31. PubMed ID: 4794886 [No Abstract] [Full Text] [Related]
15. Interactions of narcotics and their antagonists with human serum esterase. V: Hidden agonistic effects. Gero A; Capetola RJ Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):274-83. PubMed ID: 4447409 [No Abstract] [Full Text] [Related]
16. Interactions of narcotics and their antagonists with human serum esterase. IV. Drug-receptor interaction at the acceleratory site. Gero A Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):41-6. PubMed ID: 4775937 [No Abstract] [Full Text] [Related]
17. Antagonists in the homobenzomorphan series. Takeda M; Konda M; Inoue H; Saito S; Kugita H Adv Biochem Psychopharmacol; 1973; 8(0):113-21. PubMed ID: 4794865 [No Abstract] [Full Text] [Related]
18. Reversal by narcotics and narcotic antagonists of pain-induced functional impairment. RodrÃguez R; Pardo EG Adv Biochem Psychopharmacol; 1973; 8(0):213-23. PubMed ID: 4795077 [No Abstract] [Full Text] [Related]
19. Structural features associated with narcotics and narcotic antagonists. Bella DD Neuropharmacology; 1975 Dec; 14(12):941-9. PubMed ID: 768801 [No Abstract] [Full Text] [Related]
20. Physicochemical properties of opiate - cerebroside sulfate complex. Cho TM; Loh HH; Way EL Proc West Pharmacol Soc; 1975; 18():176-80. PubMed ID: 1178664 [No Abstract] [Full Text] [Related] [Next] [New Search]